治疗儿童类固醇敏感性脏综合征的非皮质类固醇免疫抑制药物
Nicholas G Larkins1, Deirdre Hahn2, Isaac D Liu3
1Department of Nephrology, Princess Margaret Hospital, Subiaco, Australia.
The Cochrane database of systematic reviews
|November 8, 2024
概括
利图西马布有效地减少了患有类固醇敏感性脏综合征 (SSNS) 的儿童的复发. 非皮质类固醇免疫抑制剂提供了替代品,但它们的最佳使用和安全性需要在正在进行的研究中进一步调查.
科学领域:
- 儿科脏病学 儿科脏病学
- 免疫抑制疗法 免疫抑制疗法
- 临床试验分析
背景情况:
- 类固醇敏感性性综合征 (SSNS) 影响了许多儿童,80%的儿童经历了复发.
- 频繁复发带来皮质类固醇的风险,需要替代治疗.
- 目前的治疗指南缺乏关于SSNS频繁复发的最佳二线药物的共识.
研究的目的:
- 为了评估非皮质类固醇免疫抑制药物的疗效和安全性,在儿童SSNS.
- 在复发和第一次发作的SSNS病例中评估好处和危害.
- 为临床决策提供最新的基于证据的审查.
主要方法:
- 随机对照试验 (RCT) 和准RCT的系统审查和元分析.
- 搜索了多个数据库,包括Cochrane脏和移植注册表,CENTRAL,MEDLINE和EMBASE.
- 评估了偏见风险,并使用了GRADE方法来评估证据的确定性.
主要成果:
- 与安慰剂相比,Rituximab显著降低了SSNS在6个月和12个月的复发率.
- 利图西马布的疗效与塔克罗利斯和甲酸莫菲提尔 (MMF) 相同或更高.
- 列瓦米索尔和氨酸抑制剂 (CNIs) 显示出潜在的益处,CNIs可能会超过MMF.
结论:
- 利图西马布是治疗儿童复发性SSNS的一个有价值的药物.
- 比较数据表明,CNI与货币货币基金的潜在优势,以及levamisole的类似有效性.
- 目前正在进行的研究对于完善频繁复发的SSNS的治疗策略至关重要.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
96
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
96
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
222
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
222
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
237
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
237
01:29Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
01:29Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120